Poolbeg Pharma (POLB) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free POLB Stock Alerts GBX 11.80 +0.20 (+1.72%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFavourable Signals For Poolbeg Pharma: Numerous Insiders Acquired Stockfinance.yahoo.com - March 27 at 7:22 AMPoolbeg Pharma moves closer to locking down IP protection for key...proactiveinvestors.com - March 20 at 5:53 PMPoolbeg Pharma PLC Announces Director/PDMR Shareholdingfinance.yahoo.com - February 22 at 8:23 AMPoolbeg Pharma chair discusses shift to executive role; hVIVO share salefinance.yahoo.com - February 20 at 7:05 AMPoolbeg Pharma PLC Announces Director Share Purchasefinance.yahoo.com - February 19 at 12:39 PMWe Think Poolbeg Pharma (LON:POLB) Can Afford To Drive Business Growthfinance.yahoo.com - February 15 at 1:16 PMPoolbeg Pharma announces board role change and launch of EIPmsn.com - February 15 at 7:37 AMPoolbeg Pharma PLC Announces Board Role Change and Launch of EIPfinance.yahoo.com - February 15 at 2:20 AMPoolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapiesfinance.yahoo.com - February 12 at 8:44 AMPoolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRSfinance.yahoo.com - February 12 at 3:44 AMPoolbeg Pharma's new VP of Clinical Operations Laura Maher aims to help progress development assetsfinance.yahoo.com - February 8 at 7:18 AMPoolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRSfinance.yahoo.com - January 17 at 8:13 AMPoolbeg Pharma identifies promising RSV drug candidates as part of AI-led programmemsn.com - December 20 at 8:27 AMPoolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis Updatefinance.yahoo.com - December 20 at 8:27 AMPoolbeg Pharma PLC Announces POLB 001 Data Presented at ASHfinance.yahoo.com - December 11 at 8:23 AMPoolbeg Pharma non-exec steps down from boardproactiveinvestors.com - November 30 at 10:39 AMPoolbeg Pharma PLC Announces Directorate Changefinance.yahoo.com - November 30 at 10:39 AMTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisherlse.co.uk - November 21 at 1:00 PMPoolbeg Pharma lands Japanese patent grant for lead assetproactiveinvestors.com - November 21 at 8:00 AMPoolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japanfinance.yahoo.com - November 21 at 8:00 AMFormer Amryt Pharma Leadership Team join Poolbegfinance.yahoo.com - November 9 at 10:12 AMPoolbeg Pharma "continuing its campaign to find a partner" for POLB001finance.yahoo.com - November 2 at 9:40 AMPoolbeg investor meeting will take a deep dive into lead programmeproactiveinvestors.com - November 1 at 8:53 AMPoolbeg Pharma PLC Announces POLB 001 Oncology Programme Update Meetingfinance.yahoo.com - November 1 at 8:53 AMPoolbeg advisory board endorses flu drug approachproactiveinvestors.com - October 26 at 7:32 AMPoolbeg Pharma unveils new collaboration agreementproactiveinvestors.com - October 17 at 10:14 AMPoolbeg Partners with a Nasdaq-Listed Biopharmafinance.yahoo.com - October 17 at 10:14 AMPoolbeg Pharma PLC Announces Favourable Conclusion of Patent Oppositionfinance.yahoo.com - September 29 at 5:51 AMPoolbeg Pharma shores up protection around its IPproactiveinvestors.com - September 20 at 5:42 AMPoolbeg Pharma: Third party withdraws patent oppositionproactiveinvestors.com - September 19 at 7:29 AMPoolbeg Pharma PLC Announces Immunomodulator I Patent Opposition Withdrawalfinance.yahoo.com - September 19 at 2:28 AMPoolbeg Pharma "moving forward rapidly" with POLB001finance.yahoo.com - September 13 at 5:47 PMPoolbeg Pharma PLC Announces Interim Results for the Six Months to 30 June 2023finance.yahoo.com - September 13 at 3:16 AMWe're Not Very Worried About Poolbeg Pharma's (LON:POLB) Cash Burn Ratefinance.yahoo.com - September 8 at 9:00 AMPoolbeg Pharma highlights climate change impact on infectious diseasesproactiveinvestors.com - August 30 at 9:38 AMPoolbeg Pharma makes "significant" influenza breakthrough with AIlse.co.uk - June 29 at 4:09 PMPoolbeg Pharma identifies multiple novel drug targets for flu treatmentmsn.com - June 29 at 6:08 AMPoolbeg Pharma and CytoReason identify "very exciting influenza targets"finance.yahoo.com - June 29 at 6:08 AMPoolbeg Pharma PLC Announces AI Led Programme Identifies Influenza Drug Targetsfinance.yahoo.com - June 29 at 6:08 AMSmall cap snapshot: Erdene Resources, Valeo Pharma, Avicanna, PyroGenesis, Evergreen Sustainable Enterprises...proactiveinvestors.com - June 22 at 1:32 PMPoolbeg Pharma sees "significant commercial opportunity" in oral vaccinesfinance.yahoo.com - June 22 at 1:32 PMPoolbeg Pharma consortium moves into important new phase as...Poolbeg Pharma consortium moves into important new phase as it...proactiveinvestors.com - June 22 at 8:32 AMPoolbeg Pharma PLC - Oral Vaccine Programme Moves Forwardfinance.yahoo.com - June 22 at 8:32 AMPoolbeg Pharma's new NED looking at "new opportunities" for the businessproactiveinvestors.com - May 26 at 4:56 AMPoolbeg Pharma appoints Brendan Buckley as directorproactiveinvestors.com - May 24 at 10:34 AMPoolbeg Pharma PLC Announces Board Appointmentfinance.yahoo.com - May 24 at 10:34 AMPoolbeg Pharma PLC Announces Results of Annual General Meetingfinance.yahoo.com - May 11 at 10:27 AMPoolbeg Pharma (LON:POLB) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - April 1 at 3:30 AMPoolbeg Pharma: Plenty of upside seen by corporate brokerproactiveinvestors.com - March 31 at 5:29 PMPoolbeg Pharma PLC Announces Results for the Year Ended 31 December 2022finance.yahoo.com - March 30 at 9:32 AM Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. POLB Media Mentions By Week POLB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. POLB News Sentiment▼0.000.32▲Average Medical News Sentiment POLB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. POLB Articles This Week▼01▲POLB Articles Average Week Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: REDX News Today ETX News Today AREC News Today C4XD News Today OKYO News Today HEMO News Today ONC News Today OBD News Today DEST News Today OPTI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:POLB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
